プロゲステロン受容体作動薬のグローバル市場展望 2023年-2029年：天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬

■ 英語タイトル：Progesterone Receptor Agonist Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8608）

■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8608
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[プロゲステロン受容体作動薬のグローバル市場展望 2023年-2029年：天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のプロゲステロン受容体作動薬市場規模と予測を収録しています。・世界のプロゲステロン受容体作動薬市場：売上、2018年-2023年、2024年-2029年
・世界のプロゲステロン受容体作動薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のプロゲステロン受容体作動薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「天然プロゲステロン受容体作動薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

プロゲステロン受容体作動薬のグローバル主要企業は、TherapeuticsMD、 Evestra、 Anavex Life Sciences、 Encore Therapeutics、 Lipocine、 Orion、 Exeltis、 Estetra S.A.、 Bayer Schering Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、プロゲステロン受容体作動薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のプロゲステロン受容体作動薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のプロゲステロン受容体作動薬市場：タイプ別市場シェア、2022年
・天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬

世界のプロゲステロン受容体作動薬市場：用途別、2018年-2023年、2024年-2029年
世界のプロゲステロン受容体作動薬市場：用途別市場シェア、2022年
・避妊、機能不全子宮出血、子宮内膜がん、増殖前駆体病変、月経周期調節、その他

世界のプロゲステロン受容体作動薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のプロゲステロン受容体作動薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるプロゲステロン受容体作動薬のグローバル売上、2018年-2023年
・主要企業におけるプロゲステロン受容体作動薬のグローバル売上シェア、2022年
・主要企業におけるプロゲステロン受容体作動薬のグローバル販売量、2018年-2023年
・主要企業におけるプロゲステロン受容体作動薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
TherapeuticsMD、 Evestra、 Anavex Life Sciences、 Encore Therapeutics、 Lipocine、 Orion、 Exeltis、 Estetra S.A.、 Bayer Schering Pharma

*************************************************************

・調査・分析レポートの概要
プロゲステロン受容体作動薬市場の定義
市場セグメント
世界のプロゲステロン受容体作動薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のプロゲステロン受容体作動薬市場規模
世界のプロゲステロン受容体作動薬市場規模：2022年 VS 2029年
世界のプロゲステロン受容体作動薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのプロゲステロン受容体作動薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のプロゲステロン受容体作動薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬
プロゲステロン受容体作動薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：避妊、機能不全子宮出血、子宮内膜がん、増殖前駆体病変、月経周期調節、その他
プロゲステロン受容体作動薬の用途別グローバル売上・予測

・地域別市場分析
地域別プロゲステロン受容体作動薬市場規模 2022年と2029年
地域別プロゲステロン受容体作動薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
TherapeuticsMD、 Evestra、 Anavex Life Sciences、 Encore Therapeutics、 Lipocine、 Orion、 Exeltis、 Estetra S.A.、 Bayer Schering Pharma
...

This report aims to provide a comprehensive presentation of the global market for Progesterone Receptor Agonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Progesterone Receptor Agonist. This report contains market size and forecasts of Progesterone Receptor Agonist in global, including the following market information:
Global Progesterone Receptor Agonist Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Progesterone Receptor Agonist Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Progesterone Receptor Agonist companies in 2022 (%)
The global Progesterone Receptor Agonist market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Natural Progesterone Receptor Agonist Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Progesterone Receptor Agonist include TherapeuticsMD, Evestra, Anavex Life Sciences, Encore Therapeutics, Lipocine, Orion, Exeltis, Estetra S.A. and Bayer Schering Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Progesterone Receptor Agonist manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Progesterone Receptor Agonist Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Progesterone Receptor Agonist Market Segment Percentages, by Type, 2022 (%)
Natural Progesterone Receptor Agonist
Synthetic Progesterone Receptor Agonist
Global Progesterone Receptor Agonist Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Progesterone Receptor Agonist Market Segment Percentages, by Application, 2022 (%)
Contraception
Dysfunctional Uterine Bleeding
Endometrial Cancer
Proliferative Precursor Lesions
Menstrual Cycle Regulation
Others
Global Progesterone Receptor Agonist Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Progesterone Receptor Agonist Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Progesterone Receptor Agonist revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Progesterone Receptor Agonist revenues share in global market, 2022 (%)
Key companies Progesterone Receptor Agonist sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Progesterone Receptor Agonist sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
TherapeuticsMD
Evestra
Anavex Life Sciences
Encore Therapeutics
Lipocine
Orion
Exeltis
Estetra S.A.
Bayer Schering Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Progesterone Receptor Agonist, market overview.
Chapter 2: Global Progesterone Receptor Agonist market size in revenue and volume.
Chapter 3: Detailed analysis of Progesterone Receptor Agonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Progesterone Receptor Agonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Progesterone Receptor Agonist capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Progesterone Receptor Agonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Progesterone Receptor Agonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Progesterone Receptor Agonist Overall Market Size
2.1 Global Progesterone Receptor Agonist Market Size: 2022 VS 2029
2.2 Global Progesterone Receptor Agonist Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Progesterone Receptor Agonist Sales: 2018-2029
3 Company Landscape
3.1 Top Progesterone Receptor Agonist Players in Global Market
3.2 Top Global Progesterone Receptor Agonist Companies Ranked by Revenue
3.3 Global Progesterone Receptor Agonist Revenue by Companies
3.4 Global Progesterone Receptor Agonist Sales by Companies
3.5 Global Progesterone Receptor Agonist Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Progesterone Receptor Agonist Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Progesterone Receptor Agonist Product Type
3.8 Tier 1, Tier 2 and Tier 3 Progesterone Receptor Agonist Players in Global Market
3.8.1 List of Global Tier 1 Progesterone Receptor Agonist Companies
3.8.2 List of Global Tier 2 and Tier 3 Progesterone Receptor Agonist Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Progesterone Receptor Agonist Market Size Markets, 2022 & 2029
4.1.2 Natural Progesterone Receptor Agonist
4.1.3 Synthetic Progesterone Receptor Agonist
4.2 By Type – Global Progesterone Receptor Agonist Revenue & Forecasts
4.2.1 By Type – Global Progesterone Receptor Agonist Revenue, 2018-2023
4.2.2 By Type – Global Progesterone Receptor Agonist Revenue, 2024-2029
4.2.3 By Type – Global Progesterone Receptor Agonist Revenue Market Share, 2018-2029
4.3 By Type – Global Progesterone Receptor Agonist Sales & Forecasts
4.3.1 By Type – Global Progesterone Receptor Agonist Sales, 2018-2023
4.3.2 By Type – Global Progesterone Receptor Agonist Sales, 2024-2029
4.3.3 By Type – Global Progesterone Receptor Agonist Sales Market Share, 2018-2029
4.4 By Type – Global Progesterone Receptor Agonist Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Progesterone Receptor Agonist Market Size, 2022 & 2029
5.1.2 Contraception
5.1.3 Dysfunctional Uterine Bleeding
5.1.4 Endometrial Cancer
5.1.5 Proliferative Precursor Lesions
5.1.6 Menstrual Cycle Regulation
5.1.7 Others
5.2 By Application – Global Progesterone Receptor Agonist Revenue & Forecasts
5.2.1 By Application – Global Progesterone Receptor Agonist Revenue, 2018-2023
5.2.2 By Application – Global Progesterone Receptor Agonist Revenue, 2024-2029
5.2.3 By Application – Global Progesterone Receptor Agonist Revenue Market Share, 2018-2029
5.3 By Application – Global Progesterone Receptor Agonist Sales & Forecasts
5.3.1 By Application – Global Progesterone Receptor Agonist Sales, 2018-2023
5.3.2 By Application – Global Progesterone Receptor Agonist Sales, 2024-2029
5.3.3 By Application – Global Progesterone Receptor Agonist Sales Market Share, 2018-2029
5.4 By Application – Global Progesterone Receptor Agonist Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Progesterone Receptor Agonist Market Size, 2022 & 2029
6.2 By Region – Global Progesterone Receptor Agonist Revenue & Forecasts
6.2.1 By Region – Global Progesterone Receptor Agonist Revenue, 2018-2023
6.2.2 By Region – Global Progesterone Receptor Agonist Revenue, 2024-2029
6.2.3 By Region – Global Progesterone Receptor Agonist Revenue Market Share, 2018-2029
6.3 By Region – Global Progesterone Receptor Agonist Sales & Forecasts
6.3.1 By Region – Global Progesterone Receptor Agonist Sales, 2018-2023
6.3.2 By Region – Global Progesterone Receptor Agonist Sales, 2024-2029
6.3.3 By Region – Global Progesterone Receptor Agonist Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Progesterone Receptor Agonist Revenue, 2018-2029
6.4.2 By Country – North America Progesterone Receptor Agonist Sales, 2018-2029
6.4.3 US Progesterone Receptor Agonist Market Size, 2018-2029
6.4.4 Canada Progesterone Receptor Agonist Market Size, 2018-2029
6.4.5 Mexico Progesterone Receptor Agonist Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Progesterone Receptor Agonist Revenue, 2018-2029
6.5.2 By Country – Europe Progesterone Receptor Agonist Sales, 2018-2029
6.5.3 Germany Progesterone Receptor Agonist Market Size, 2018-2029
6.5.4 France Progesterone Receptor Agonist Market Size, 2018-2029
6.5.5 U.K. Progesterone Receptor Agonist Market Size, 2018-2029
6.5.6 Italy Progesterone Receptor Agonist Market Size, 2018-2029
6.5.7 Russia Progesterone Receptor Agonist Market Size, 2018-2029
6.5.8 Nordic Countries Progesterone Receptor Agonist Market Size, 2018-2029
6.5.9 Benelux Progesterone Receptor Agonist Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Progesterone Receptor Agonist Revenue, 2018-2029
6.6.2 By Region – Asia Progesterone Receptor Agonist Sales, 2018-2029
6.6.3 China Progesterone Receptor Agonist Market Size, 2018-2029
6.6.4 Japan Progesterone Receptor Agonist Market Size, 2018-2029
6.6.5 South Korea Progesterone Receptor Agonist Market Size, 2018-2029
6.6.6 Southeast Asia Progesterone Receptor Agonist Market Size, 2018-2029
6.6.7 India Progesterone Receptor Agonist Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Progesterone Receptor Agonist Revenue, 2018-2029
6.7.2 By Country – South America Progesterone Receptor Agonist Sales, 2018-2029
6.7.3 Brazil Progesterone Receptor Agonist Market Size, 2018-2029
6.7.4 Argentina Progesterone Receptor Agonist Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Progesterone Receptor Agonist Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Progesterone Receptor Agonist Sales, 2018-2029
6.8.3 Turkey Progesterone Receptor Agonist Market Size, 2018-2029
6.8.4 Israel Progesterone Receptor Agonist Market Size, 2018-2029
6.8.5 Saudi Arabia Progesterone Receptor Agonist Market Size, 2018-2029
6.8.6 UAE Progesterone Receptor Agonist Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 TherapeuticsMD
7.1.1 TherapeuticsMD Company Summary
7.1.2 TherapeuticsMD Business Overview
7.1.3 TherapeuticsMD Progesterone Receptor Agonist Major Product Offerings
7.1.4 TherapeuticsMD Progesterone Receptor Agonist Sales and Revenue in Global (2018-2023)
7.1.5 TherapeuticsMD Key News & Latest Developments
7.2 Evestra
7.2.1 Evestra Company Summary
7.2.2 Evestra Business Overview
7.2.3 Evestra Progesterone Receptor Agonist Major Product Offerings
7.2.4 Evestra Progesterone Receptor Agonist Sales and Revenue in Global (2018-2023)
7.2.5 Evestra Key News & Latest Developments
7.3 Anavex Life Sciences
7.3.1 Anavex Life Sciences Company Summary
7.3.2 Anavex Life Sciences Business Overview
7.3.3 Anavex Life Sciences Progesterone Receptor Agonist Major Product Offerings
7.3.4 Anavex Life Sciences Progesterone Receptor Agonist Sales and Revenue in Global (2018-2023)
7.3.5 Anavex Life Sciences Key News & Latest Developments
7.4 Encore Therapeutics
7.4.1 Encore Therapeutics Company Summary
7.4.2 Encore Therapeutics Business Overview
7.4.3 Encore Therapeutics Progesterone Receptor Agonist Major Product Offerings
7.4.4 Encore Therapeutics Progesterone Receptor Agonist Sales and Revenue in Global (2018-2023)
7.4.5 Encore Therapeutics Key News & Latest Developments
7.5 Lipocine
7.5.1 Lipocine Company Summary
7.5.2 Lipocine Business Overview
7.5.3 Lipocine Progesterone Receptor Agonist Major Product Offerings
7.5.4 Lipocine Progesterone Receptor Agonist Sales and Revenue in Global (2018-2023)
7.5.5 Lipocine Key News & Latest Developments
7.6 Orion
7.6.1 Orion Company Summary
7.6.2 Orion Business Overview
7.6.3 Orion Progesterone Receptor Agonist Major Product Offerings
7.6.4 Orion Progesterone Receptor Agonist Sales and Revenue in Global (2018-2023)
7.6.5 Orion Key News & Latest Developments
7.7 Exeltis
7.7.1 Exeltis Company Summary
7.7.2 Exeltis Business Overview
7.7.3 Exeltis Progesterone Receptor Agonist Major Product Offerings
7.7.4 Exeltis Progesterone Receptor Agonist Sales and Revenue in Global (2018-2023)
7.7.5 Exeltis Key News & Latest Developments
7.8 Estetra S.A.
7.8.1 Estetra S.A. Company Summary
7.8.2 Estetra S.A. Business Overview
7.8.3 Estetra S.A. Progesterone Receptor Agonist Major Product Offerings
7.8.4 Estetra S.A. Progesterone Receptor Agonist Sales and Revenue in Global (2018-2023)
7.8.5 Estetra S.A. Key News & Latest Developments
7.9 Bayer Schering Pharma
7.9.1 Bayer Schering Pharma Company Summary
7.9.2 Bayer Schering Pharma Business Overview
7.9.3 Bayer Schering Pharma Progesterone Receptor Agonist Major Product Offerings
7.9.4 Bayer Schering Pharma Progesterone Receptor Agonist Sales and Revenue in Global (2018-2023)
7.9.5 Bayer Schering Pharma Key News & Latest Developments
8 Global Progesterone Receptor Agonist Production Capacity, Analysis
8.1 Global Progesterone Receptor Agonist Production Capacity, 2018-2029
8.2 Progesterone Receptor Agonist Production Capacity of Key Manufacturers in Global Market
8.3 Global Progesterone Receptor Agonist Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Progesterone Receptor Agonist Supply Chain Analysis
10.1 Progesterone Receptor Agonist Industry Value Chain
10.2 Progesterone Receptor Agonist Upstream Market
10.3 Progesterone Receptor Agonist Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Progesterone Receptor Agonist Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

プロゲステロン受容体作動薬のグローバル市場展望 2023年-2029年：天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬

グローバル市場調査会社